The Mednax Center for Research, Education, Quality and Safety (CREQS) empowers health care providers to Take great care of the patient, every day and in every way.TM As part of our ongoing commitment to improving patient care through evidence-based medicine, we engage in clinical research, education, continuous quality improvement and safety initiatives. Our efforts contribute to better patient outcomes and reduced long-term health system costs, not only for our patients and hospital partners, but for all patients and providers across our specialty areas.
To help facilitate and support research efforts, Mednax established a Research Advisory Committee (RAC). The goal of the RAC is to design, implement and maintain a program for clinical research oversight and support that enables our practices to conduct research that is safe, effective, financially viable and legally compliant, while optimizing research opportunities. The RAC’s multidisciplinary approach involves the collaboration of both clinical and business professionals, including finance, legal and compliance experts, and has ultimately enhanced our research efforts and improved overall process flow.
With participating clinicians located throughout the country, the RAC supports a comprehensive scope of research efforts, allowing for a more in-depth look at our specialties. This nationwide perspective allows us to better anticipate future needs and opportunities.
- Collaborative Institutional Training Initiative (CITI) Instructions
- Interest Disclosure Instructions
Learn more about current research trials:
Women who are pregnant with a singleton within a certain gestation range and experiencing premature rupture of membranes are given a second course of antenatal steroids. This trial looks to discover the impact of a booster course of antenatal steroids on neonatal morbidities, including respiratory distress syndrome.
TRIDENT COVID-19: Center For Innovative Trials In Children And Adults (TRIDENT)- COVID-19
Pediatrix Medical Group and Duke Clinical Research Institute invite you to help to facilitate a study called TRIDENT COVID-19. This study is a follow-up registry study of infants who tested positive for the COVID-19 virus or whose mothers tested positive for the COVID-19 virus. The study involves completion of questionnaires when the infant is 6 and 12 months of age and review of infant and maternal medical records.
This study will help us to better understand the medical and social outcomes of mothers and children that have been exposed to and/or diagnosed with the COVID-19 virus. We do not know the long-term impact of this new infection on women or their newborn infants. Important information from this study will inform how we can improve therapies for pregnant women and their children.
TRIDENT Flyer – Spanish
Clinician Study Info Sheet COVID
Parent Recruitment Brochure English
Parent Recruitment Brochure Spanish
CONTACT FOR MORE INFORMATION
Dr. Rachel Greenberg
Duke Clinical Research Institute
Dr. Reese Clark
VP Clinical Research, MEDNAX
This study is funded by NIH/NCATS Grant 3U24TR001608-05S2
PDA Post NICU Discharge (PDA)
Varying treatment options are available for premature infants with patent ductus arteriosus (PDA). This post-discharge study follows NICU patients discharged with PDA, tracking spontaneous closure rates and incidences of pulmonary and/or cardiac events to identify risk factors associated with adverse outcomes.
Long QT and Hearing Loss Registry
This observational study follows neonatal patients greater than one week of age diagnosed with unilateral or bilateral sensorineural hearing loss to determine the true incidence of long QT. The goal of the study is to determine the incidence of an abnormal ECG and the percentages of these patients with an identifiable genetic mutation as well as patients with an abnormal genetic mutation regardless of the ECG.
Access articles published by Mednax clinicians.
Our commitment to clinical and research excellence is evidenced by our comprehensive educational and professional development opportunities offered online or during live sessions. Each year, thousands of health care providers worldwide take advantage of educational programs hosted by Mednax. The Mednax Center for Research, Education, Quality and Safety is accredited with commendation by the Accreditation Council for Continuing Medical Education and accredited by the American Nurses Credentialing Center’s Commission on Accreditation.
As thought leaders in a variety of medical specialties, our conferences attract a broad range of clinicians – from students to recent graduates to seasoned providers.
Specialty Review in Neonatology
An intensive and comprehensive review of neonatal medicine, this course is invaluable to those preparing for certifying examinations, as well as new or current fellows in training seeking an outstanding fundamental pathophysiology course in neonatal-perinatal medicine.
NEO: The Conference for Neonatology
One of the premier national conferences in neonatal medicine, NEO addresses cutting edge, yet practical aspects of newborn medicine.
Quality and Safety
Through the leadership of our affiliated clinicians and with the support of our CREQS, we have cultivated a culture of continuous quality improvement and safety. This is the cornerstone of our success and helps us fulfill our mission. Our team of clinical specialists leads and provides oversight for several national quality and safety programs in various subspecialties.
National Opioid Management Collaborative (NOPC) – The Mednax NOPC addresses the diagnosis, treatment and management of Neonatal Abstinence Syndrome, as well as other key contributing factors such as managing opioid addiction in pregnancy and responsible prescribing practices in the perinatal period.
Mednax NICU Breakthrough Collaborative
Achieving optimal outcomes in the practice of neonatal intensive care is challenging and complex. The Mednax NICU Breakthrough Collaborative provides support for 100+ participating NICUs striving to improve a variety of neonatal outcomes, including mortality, late onset sepsis, NEC, bronchopulmonary dysplasia, intraventricular hemorrhage and more.
Enhanced Recovery after Cesarean (ERAC) Collaborative
Enhanced recovery after surgery programs have demonstrated value by improving health outcomes and patient satisfaction while reducing costs. Our ERAC Collaborative gives our affiliated practices and hospital partners tools to assess need and implement ERAC programs.
Best Practices: Amniotic Fluid Volume Assessment Collaborative
The Amniotic Fluid Volume Assessment Collaborative will help our affiliated maternal-fetal medicine practices establish consensus and minimize clinical variations in the definitions and management of abnormal amniotic fluid volume.
ACOG SCOPE Certification Collaborative
The importance of safety is self-evident but the application process to achieve the ACOG Safety Certification of Outpatient Practice Excellence (SCOPE) can be challenging. The ACOG SCOPE Certification Collaborative helps our affiliated practices develop an operations safety manual addressing the content areas required in the SCOPE application.
Shared MFM Content Repository Collaborative
To minimize duplication of efforts and promote best practices in operations and patient education, the Shared MFM Content Repository Collaborative promotes document sharing, including patient instructions, checklists, orders sets and more, among our affiliated practices.
Mednax Cardiology Quality Collaborative (MCQC)
The Mednax Cardiology Quality Collaborative (MCQC) leverages the power of 20 cardiology practices and over 125 Pediatric Cardiology providers across the country to compare clinical and administrative best practices for continuous quality improvement both with individual projects and through an iterative process anchored in monthly teleconferences and yearly/bi-yearly meetings. MCQC has worked closely with the American College of Cardiology’s Adult Congenital and Pediatric Cardiology Quality Network (ACC – ACPC QNet) to develop and submit quality metric process and outcomes data as part of this national collaborative backed by ACC’s National Cardiac Database Registry (NCDR).
Mednax QCDR is certified by The Centers for Medicare and Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR). Our clinicians can utilize the Mednax QCDR to submit MIPS and QCDR quality metric data and Improvement Activities directly to CMS. Services are provided to Mednax-affiliated clinicians who participate in the registry.
For 2021, in addition to CMS MIPS measures, Mednax includes the following QCDR measures in its QCDR:
- Mednax 53 – Use of Capnography
- Mednax 54 – Labor Epidural Failure
- Mednax 55 – Use of ASPECTS for Non-Contrast CT Head
- Mednax 56 – Opioid PEG Test
- Quantum 31 – Central Line Ultrasound Guidance
- AQI 56 – Neuraxial Technique for TKA
- QMM16 – IVC Filter
- QMM17 – O-RADS
- QMM18 – Breast Cancer Risk Score
- QMM19 – DXA-FRAX Measure
- QMM20 – Open Pressure in Lumbar Puncture
Practicing critical decision-making, communication, task and teamwork skills with in situ scenarios promotes optimized clinical performance for high-risk, low-volume critical situations. To meet the needs of our health care providers and hospital partners, as well as our patients, Mednax offers a variety of customized simulation programs to instill competence and confidence with one goal in mind: improved outcomes. The highly interactive programs incorporate rapid cycle deliberate practice (RCDP) approaches to support maternal-fetal medicine, neonatology and hospital-based medicine practices including obstetrics and pediatrics.
Our Simulation Program has earned Full Accreditation status from the Society for Simulation in Healthcare (SSH) in the area of Teaching/Education from April 1, 2020 to December 31, 2025.
Crew Resource Management (CRM) training forms the foundation of our High Reliability Organization (HRO) Patient Safety Initiative. We have adopted CRM strategies – proven to optimize safety in aviation and aeronautics industries – to become an HRO so our health care providers can deliver the safest care while communicating efficiently and effectively. Mednax has implemented HRO programs across the continuum of care, including our critical care specialties and women’s and children’s service lines.
Collaborative innovation is the pathway towards excellence in research, education, quality and safety. Because of the critical role innovation plays, our team strives to integrate the latest technological advances, artificial or augmented intelligence, genetic discoveries and mobile applications, into everyday care. Tele-and mobile health, virtual reality, next generation sequencing, point-of-care diagnostics and advanced data analytics are currently shaping the future of medicine. Our team is actively engaged in designing projects that will allow us to prevent disease, offer precision care and further optimize patient outcomes.
To promote our public policy efforts at both the state and national levels, Mednax’s Government Relations team collaborates with physician groups, professional societies and hospital partners to safeguard access to care for clinical services.